tirzepatide and restless legs Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults Tirzepatide for Medical Weight Loss

Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis

Most users report bloating onset within the first 1 to 2 weeks of starting semaglutide or within the first week after each dose escalation

Associations of MTHFR C677T and MTRR A66G Gene Polymorphisms with Metabolic Syndrome: A Case-Control Study in Northern China. International Journal of Molecular Sciences, vol

Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist. Diabetes, Metabolic Syndrome and Obesity, vol

Handle using appropriate laboratory safety protocols.